Hydroxyapatite surface calcium sites (HA)

Hydroxyapatite is the primary mineral constituent of vertebrate bone and teeth, existing as a crystalline lattice of calcium, phosphate, and hydroxyl ions (Nancollas et al., 2006). The surface calcium (Ca2+) sites of these crystals are of significant therapeutic importance as they serve as the high-affinity binding targets for bone-seeking agents, most notably bisphosphonates (Russell, 2011). These drugs mimic the structure of pyrophosphate and chelate the surface calcium ions, allowing for selective accumulation in the skeletal system, particularly at sites of active bone remodeling (PubChem CID 14781). This localization enables the drugs to effectively inhibit osteoclast-mediated bone resorption, making hydroxyapatite a critical target in the management of osteoporosis, Paget's disease, and skeletal complications of malignancy. Additionally, radiopharmaceuticals like Technetium-99m medronate utilize these surface sites for diagnostic bone imaging.

Other names

Calcium hydroxyapatiteBone mineralHAPCrystalline hydroxyapatite

Bisphosphonates and other bone-seeking agents bind to the surface calcium ions of hydroxyapatite crystals via chelation, concentrating the drug at sites of active bone turnover to inhibit osteoclast activity or deliver localized radiation.